TP53 and neutropenia: Patients with SDS are characterized by moderate to severe neutropenia, due to deficient myelopoiesis caused by excessive apoptosis of bone marrow hematopoietic progenitors (Dror et al. 2001) and increased p53 signaling (Elghetany and Alter 2002).